Matt Zapadka Quoted in NutraIngredients Article on What the Fall of Chevron Means for the Dietary Supplements Industry

Matt Zapadka, AGG Intellectual Property and Litigation partner and member of the Dietary Supplements industry team, was quoted in a NutraIngredients article titled “The Fall of Chevron and the Potential Implications for Dietary Supplements.” The article discusses how the Supreme Court of the United States’ decision to overturn Chevron deference in Loper Bright Enterprises, Inc. v. Raimondo may impact the dietary supplements industry.

In regard to the Dietary Supplement Health and Education Act of 1994 (“DSHEA”), Matt said that for Chevron to have applied there had to have been ambiguity in the statute and there isn’t much ambiguity in DSHEA. He added that the Drug Preclusion, or the race to market provision (201(ff)(3)), appears to be the issue with the biggest target on its back.

To read the full article, please click here.